Miljenko V. Pilepich

10.1k citations

111 papers · 7.6k indexed · 4 hit papers · h-index 47

Pulmonary and Respiratory Medicine top 0.1%
Radiation top 0.1%
Surgery top 2%
Oncology top 2%
Rheumatology top 1%

Co-authors: David J. Grignon Sucha O. Asbell C.A. Lawton Gerald E. Hanks William T. Sause Kathryn Winter William U. Shipley John M. Krall
Topics: Prostate Cancer Diagnosis and Treatment (69 papers)Prostate Cancer Treatment and Research (64 papers)Advanced Radiotherapy Techniques (26 papers)
Cited by: Radiation Pulmonary and Respiratory Medicine Rheumatology
Journals: JAMA Journal of Clinical Oncology Cancer
Partner nations: United States Canada Puerto Rico

In The Last Decade

Miljenko V. Pilepich

110 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

2005 665 citations Miljenko V. Pilepich, Kathryn Winter et al. International Journal of Radiation Oncology*Biology*Physics profile →
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

2001 594 citations Miljenko V. Pilepich, Kathryn Winter et al. International Journal of Radiation Oncology*Biology*Physics profile →
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

1997 492 citations Miljenko V. Pilepich, Richard Caplan et al. Journal of Clinical Oncology profile →
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

2008 451 citations Mack Roach, Kyounghwa Bae et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Miljenko V. Pilepich

Since Specialization

Citations

This map shows the geographic impact of Miljenko V. Pilepich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miljenko V. Pilepich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miljenko V. Pilepich more than expected).

Fields of papers citing papers by Miljenko V. Pilepich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miljenko V. Pilepich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miljenko V. Pilepich. The network helps show where Miljenko V. Pilepich may publish in the future.

Co-authorship network of co-authors of Miljenko V. Pilepich

This figure shows the co-authorship network connecting the top 25 collaborators of Miljenko V. Pilepich. A scholar is included among the top collaborators of Miljenko V. Pilepich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miljenko V. Pilepich. Miljenko V. Pilepich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02 2008 ·Journal of Clinical Oncology ·Matthew R. Smith,Kyounghwa Bae,Jason A. Efstathiou,Gerald E. Hanks,Miljenko V. Pilepich,Howard M. Sandler,William U. Shipley	47
2	Protein Kinase A RI-α Predicts for Prostate Cancer Outcome: Analysis of Radiation Therapy Oncology Group Trial 86-10 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Li‐Yan Khor,Kyounghwa Bae,Tahseen Al‐Saleem,Elizabeth H. Hammond,David J. Grignon,William T. Sause,Miljenko V. Pilepich,Paul Okunieff,Howard M. Sandler,Alan Pollack	27
3	Long-Term Treatment Sequelae After External Beam Irradiation With or Without Hormonal Manipulation for Adenocarcinoma of the Prostate: Analysis of Radiation Therapy Oncology Group Studies 85-31, 86-10, and 92-02 2007 ·International Journal of Radiation OncologyBiologyPhysics ·C.A. Lawton,(unknown),Miljenko V. Pilepich,Gerald E. Hanks,William U. Shipley	51
4	Phase III Study of Pentosanpolysulfate (PPS) in Treatment of Gastrointestinal Tract Sequelae of Radiotherapy 2006 ·American Journal of Clinical Oncology ·Miljenko V. Pilepich,Rebecca Paulus,William St Clair,R.A. Brasacchio,Robert A. Rostock,Robert C. Miller	7
5	Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31breakdown → 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Miljenko V. Pilepich,Kathryn Winter,C.A. Lawton,Robert E. Krisch,Harvey B. Wolkov,Benjamin Movsas,Eugen B. Hug,Sucha O. Asbell,David J. Grignon	665
6	Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate 2001 ·International Journal of Radiation OncologyBiologyPhysics ·C.A. Lawton,Kathryn Winter,Kevin Murray,Mitchell Machtay,J Mesić,Gerald E. Hanks,Christopher T. Coughlin,Miljenko V. Pilepich	291
7	Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials 2000 ·International Journal of Radiation OncologyBiologyPhysics ·Mack Roach,Jiandong Lu,Miljenko V. Pilepich,Sucha O. Asbell,(unknown),Roger Terry,David J. Grignon	124
8	Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group 1995 ·Urology ·Miljenko V. Pilepich,William T. Sause,William U. Shipley,John M. Krall,C.A. Lawton,David Grignon,Muhyi Al‐Sarraf,Ross A. Abrams,Richard Caplan,Madhu J. John,Marvin Rotman,(unknown),R. L. Scotte Doggett,P. Rubin,Mark S. Soloway	393
9	Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Miljenko V. Pilepich,Jan W. Buzydlowski,Madhu J. John,P. Rubin,D.G. McGowan,Víctor A. Marcial	24
10	Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: A preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07 1995 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),William T. Sause,Elizabeth H. Hammond,Philip Rubin,Carlos A. Perez,Miljenko V. Pilepich,(unknown),Dennis L. Parker	4
11	Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: Implications of RTOG data for patient management and trial design and stratification 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Gerald E. Hanks,John M. Krall,Miljenko V. Pilepich,Sucha O. Asbell,Carlos A. Perez,Philip Rubin,William T. Sause,R. L. Scotte Doggett	40
12	Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Gerald E. Hanks,Sucha O. Asbell,John M. Krall,Carlos A. Pérez,(unknown),Philip Rubin,William T. Sause,Miljenko V. Pilepich	71
13	Preliminary Results of a Phase I/II Study of Sodium Pentosanpolysulfate in the Treatment of Chronic Radiation-Induced Proctitis 1990 ·American Journal of Clinical Oncology ·Perry W. Grigsby,Miljenko V. Pilepich,C. Lowell Parsons	37
14	Postoperative radiotherapy in the treatment of extremity soft tissue sarcomas 1990 ·International Journal of Radiation OncologyBiologyPhysics ·William Pao,Miljenko V. Pilepich	45
15	Impact of surgical staging in evaluating the radiotherapeutic outcome in rtog phase III study for A2 and B prostate carcinoma 1989 ·International Journal of Radiation OncologyBiologyPhysics ·Sucha O. Asbell,Karen Martz,Miljenko V. Pilepich,(unknown),William T. Sause,R. L. Scotte Doggett,Carlos A. Perez	20
16	Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma 1989 ·Cancer ·M. Elizabeth Hammond,William T. Sause,Karen Martz,Miljenko V. Pilepich,Sucha O. Asbell,Philip Rubin,Robert P. Myers,George M. Farrow	24
17	Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06 1988 ·International Journal of Radiation OncologyBiologyPhysics ·Sucha O. Asbell,John M. Krall,Miljenko V. Pilepich,(unknown),William T. Sause,Gerald E. Hanks,Carlos A. Perez	147
18	Prognostic significance of nodal involvement in locally advanced (stage C) carcinoma of prostate—RTOG experience 1987 ·Urology ·Miljenko V. Pilepich,Richard J. Johnson,Carlos A. Perez,John M. Krall,(unknown),M. Zinninger,William T. Sause,Gerald E. Hanks,Karen Martz	8
19	Radiation therapy in the treatment of chemodectomas 1987 ·The Laryngoscope ·(unknown),Miljenko V. Pilepich,Gershon J. Spector,Cherie Perez	71
20	Preliminary report on phase III RTOG studies of extended-field irradiation in carcinoma of the prostate 1983 ·American Journal of Clinical Oncology ·Miljenko V. Pilepich,Thomas F. Pajak,(unknown),Sucha O. Asbell,Joanne Stetz,M. Zinninger,Henry P. Plenk,Richard J. Johnson,S. Grant Mulholland,Bruce J. Walz,Leslie A. Kalish	15

About Miljenko V. Pilepich

Miljenko V. Pilepich is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Rheumatology, having authored 111 papers that have together received 7.6k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (64 papers) and Advanced Radiotherapy Techniques (26 papers). The work is most often cited by research in Radiation (1.9k citations), Pulmonary and Respiratory Medicine (6.3k citations) and Rheumatology (966 citations). Miljenko V. Pilepich has collaborated with scholars based in United States, Canada and Puerto Rico. Frequent co-authors include David J. Grignon, Sucha O. Asbell, C.A. Lawton, Gerald E. Hanks, William T. Sause, Kathryn Winter, William U. Shipley, John M. Krall, J Mesić and Kyounghwa Bae. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact